Saturday 7 November 2026 Export GERN’s income statement to Excel — free account

Geron Corporation

GERN Healthcare Biotechnology

Geron Corporation’s revenue for fiscal 2025 (year ended December 2025) was $183.9 million, up 138.8% from fiscal 2024.

Revenue: +27.5%
EPS: +106.7%
Free cash flow: +176.1%
Total debt: +0.99%

Quarter to September 2026, against a year earlier

0.98 0.03 +3.16%

Follow GERN

Alert me

Market cap: $610.4M
P/E: 0.0×
Fwd P/E: −20.3×
Dividend yield: —
F-score: 3/9
Altman Z: −2.24
Beneish M: −1.70
Dividend safety: n/a

Overview

	Older periods	Dec '25	Mar '26	Jun '26	Sep '26
P/E ratio Full definition →	+8 more quarters Free account	0.00	0.00	0.00	0.00
P/S ratio Full definition →		4.79	5.09	4.20	3.80
P/FCF ratio Full definition →		0.00	0.00	0.00	0.00
P/Operating CF Full definition →		(39.88)	(15.85)	(54.24)	80.54
P/B ratio Full definition →		3.90	4.35	3.93	3.65
Price to Tangible BV Full definition →		3.90	4.35	3.93	3.65
EV/Sales Full definition →		3.87	4.46	3.65	3.36
EV/EBITDA Full definition →		0.00	0.00	0.00	0.00
EV/Operating CF Full definition →		(6.41)	(6.94)	(6.53)	(8.07)
EV/FCF Full definition →		(6.40)	(6.92)	(6.51)	(8.01)
Quick Ratio Full definition →		3.58	4.87	5.07	4.53
Current Ratio Full definition →		4.66	6.78	6.92	6.31
Net Debt/EBITDA Full definition →		9.09	650.34	14.52	(28.16)
Debt/Assets Full definition →		20.95%	22.44%	23.15%	22.85%
Debt/Equity Full definition →		0.53	0.52	0.55	0.53
Asset Turnover Full definition →		0.32	0.36	0.38	0.40
Operating CF/Net income Full definition →		0.76	17.27	0.95	7.61
Capex/Depreciation Full definition →		0.00	0.55	2.86	(0.94)
Interest Coverage Full definition →		(3.50)	0.02	(1.75)	0.80
Research and Development Expense of Revenue Full definition →		28.22%	28.85%	38.33%	21.11%
Selling, General and Administrative Expense of Revenue Full definition →		86.78%	68.34%	67.61%	59.32%
Intangible Assets out of Total Assets Full definition →		0.00	0.00	0.00	0.00
Share Based Compensation of Revenue Full definition →		12.06%	9.48%	8.61%	8.00%
Graham Net Nets Full definition →		0.20	0.19	0.22	0.20
Graham Number Full definition →		0.00	0.00	0.00	0.00
Earnings Yield Full definition →		(9.85%)	(7.07%)	(8.23%)	(5.97%)
Free Cash Flow Yield Full definition →		(12.62%)	(12.66%)	(13.37%)	(11.02%)
Revenue per Share Full definition →		0.07	0.08	0.09	0.09
Operating CF per Share Full definition →		(0.03)	(0.09)	(0.02)	0.02
Capex per Share Full definition →		0.00	0.00	0.00	0.00
Free Cash Flow per Share Full definition →		(0.03)	(0.09)	(0.02)	0.02
Cash per Share Full definition →		0.54	0.47	0.45	0.43
Shareholders Equity per Share Full definition →		0.34	0.34	0.33	0.34
Interest Debt per Share Full definition →		0.00	0.00	0.00	0.00
Book value per Share Full definition →		0.34	0.34	0.33	0.34
Free Cash Flow Full definition →		(22.07)	(63.16)	(16.05)	10.11
Working Capital Full definition →		408.73	424.96	416.01	394.49
Capital Expenditures Full definition →		0.00	(0.25)	(0.22)	(0.15)
Net Current Asset Value Full definition →		175.60	193.52	185.94	168.33
EV/EBIT Full definition →		0.00	0.00	0.00	0.00
Capex to Sales Full definition →		0.00	0.00	0.00	0.00
Price to Operating Income Full definition →		0.00	0.00	0.00	0.00
Other line items
Average Receivables Full definition →		39.01	39.04	46.43	42.83
Average Payables Full definition →		9.93	10.38	8.52	13.29
Average Inventory Full definition →		77.68	94.75	96.36	111.01
Average Assets Full definition →		582.16	548.29	537.10	547.24
Average Common Equity Full definition →		253.10	248.67	239.07	237.70

Show all line items

Columns are period end dates · fundamentals updated 6 Nov 2026

Stockrow Weekly